Indigo Diabetes
De berekende faillissementskans van Indigo Diabetes over 12 maanden bedraagt 0,3% (zeer laag). Het bedrijf is actief sinds 2016 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 9 jaar |
| Bestuur | 12 |
| Vestigingen | 1 |
| Publicaties | 64 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | verkort | 21-05-2026 | 2026-00116750 |
| 31-12-2024 | verkort | 23-04-2025 | 2025-00073373 |
| 31-12-2023 | verkort | 15-05-2024 | 2024-00088813 |
| 31-12-2022 | verkort | 23-05-2023 | 2023-00095429 |
| 31-12-2021 | verkort | 05-08-2022 | 2022-20278155 |
| 31-12-2020 | verkort | 27-05-2021 | 2021-15600563 |
| 31-12-2019 | verkort | 19-05-2020 | 2020-12500448 |
| 31-12-2018 | verkort | 22-05-2019 | 2019-14100191 |
| 31-12-2017 | verkort | 23-05-2018 | 2018-13700044 |
-
Actief30-06-2023 → heden
-
Actief14-03-2023 → heden
-
Actief01-07-2022 → heden
-
Actief25-06-2021 → heden
-
Dictys BVBARechtspersoonGedelegeerd bestuurder· vast vert.: Danaè DelbekeStaatsblad-akte 17042528 (22-03-2017)Actief22-03-2017 → heden
-
Actief09-12-2016 → heden
-
Actief09-12-2016 → heden
-
Actief09-12-2016 → heden
-
Participatiemaatschappij VlaanderenRechtspersoonBestuurder· vast vert.: LEJEUNE DianeStaatsblad-akte 17000410 (02-01-2017)Actief09-12-2016 → heden
-
Actief09-12-2016 → heden
-
Actief09-12-2016 → heden
-
Actief09-12-2016 → heden
Voormalige bestuurders (2)
-
KO PARechtspersoonBestuurder· vast vert.: VAN SCHUYLENBERGH Koenraad Frank ClemensStaatsblad-akte 17000410 (02-01-2017)Voormalig— → 09-12-2016
-
Voormalig— → 09-12-2016
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| BDO BedrijfsrevisorenActief Commissaris · vertegenwoordigd door Thomas Durieux |
— | 09-12-2016 → heden |
| BDO Bedrijfsrevisoren bvActief Bedrijfsrevisor · vertegenwoordigd door Thomas Durieux |
— | 15-12-2022 → heden |
| NACE primair | 72109 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 17-11-2016 |
| Status | Actief |
| Postcode | 9052 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 44082B0103/00E000 | Vlaanderen | 6.306 m² | 1 · 1.934 m² | 20,0 m · 5 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
15-04-2026 2 ontslagnemend correctie
- Henricus van Barlingen — Bestuurder
- Paul Moraviec — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Henricus van Barlingen",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_cascade",
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-07-12",
"evidence_quote": "De raad van bestuur stelt vast dat het mandaat van Henricus van Barlingen werd be\u00EBindigd per 12 juli 2023 conform de publicatie in de bijlagen bij het Belgisch Staatsblad per nummer 24050364.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Moraviec",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_cascade",
"subkind": "rectification",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2024-02-12",
"evidence_quote": "De raad van bestuur stelt vast dat het mandaat van Paul Moraviec werd be\u00EBindigd per 12/02/2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christoph Michiels",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Tine Bassens",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Nicolas Bosschaerts",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "confirmation",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "bestuurder",
"person": null,
"reason": null,
"subkind": "confirmation",
"via_org": {
"kbo": null,
"name": "Deloitte Legal - Lawyers",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De raad van bestuur beslist hierbij volmacht te geven aan Meester Christoph Michiels, Meester Tine Bassens, dhr. Nicolas Bosschaerts en iedere medewerker van het kantoor Deloitte Legal - Lawyers, afzonderlijk handelend, met macht van indeplaatsstelling, voor de opstelling en de ondertekening van het",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-04-15",
"filing_date": "2026-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-09-02",
"unanimous": true
}
],
"is_correction": true,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Tine Bassens",
"org_rep_person_name": null,
"person_role_at_subject": "Bijzonder gevolmachtigde"
},
"co_filed_documents": [],
"corrected_publication_numac": "24050364"
}15-04-2026 2 ontslagnemend
- Henricus van Barlingen — Bestuurder
- Paul Moraviec — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Henricus van Barlingen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Paul Moraviec",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}04-04-2024 7 bestuurders benoemd
- Françoise Chombar Marie Cyrilla — Bestuurder
- Sofie Silvia Pieter Paula Baeten — Bestuurder
- Charles-Lambert Marie François Ghislain Beauduin — Bestuurder
- Evan Michael Castiglia — Bestuurder
- Danaè Helenè Pschychè Delbeke — Bestuurder
- Manuardeo — Waarnemer
- Vandewiele Group NV — Waarnemer
Technische details
{
"events": [
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vergadering beslist om tussentijdse kwijting te verlenen aan alle bestuurders voor de uitoefening van hun mandaat tot heden.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fran\u00E7oise Chombar Marie Cyrilla",
"address": null,
"birth_date": "1962-05-29",
"profession": null,
"birth_place": "Menen"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Sensinnovat BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Sensinnovat BV, vast vertegenwoordigd door Fran\u00E7oise Chombar Marie Cyrilla, geboren op 29 mei 1962 te Menen;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sofie Silvia Pieter Paula Baeten",
"address": null,
"birth_date": "1970-03-09",
"profession": null,
"birth_place": "Gent"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Qbic Venture Partners II NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Qbic Venture Partners II NV, vast vertegenwoordigd door mevrouw Sofie Silvia Pieter Paula Baeten, geboren op 9 maart 1970 te Gent;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"address": null,
"birth_date": "1959-06-19",
"profession": null,
"birth_place": "Ukkel"
},
"reason": null,
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - De heer Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin, geboren op 19 juni 1959 te Ukkel;",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Michael Castiglia",
"address": null,
"birth_date": "1984-01-14",
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Thuja Capital Management B.V",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Thuja Capital Management B.V, vast vertegenwoordigd door Evan Michael Castiglia,",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke",
"address": null,
"birth_date": "1975-01-07",
"profession": null,
"birth_place": "Roeselare"
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": null,
"name": "Dictys BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "De vergadering beslist te benoemen tot bestuurder, en dit voor een duur van zes jaar: - Dictys BV, vast vertegenwoordigd door mevrouw Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke, geboren op 7 januari 1975 te Roeselare.",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "board_snapshot",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "De vennootschap wordt bestuurd door een raad van bestuur bestaande uit maximaal vijf (5) leden, benoemd door de algemene vergadering, en die als volgt wordt samengesteld: - \u00E9\u00E9n (1) bestuurder zal de CEO van de Vennootschap zijn (de CEO Bestuurder); - \u00E9\u00E9n (1) bestuurder zal benoemd worden op bindende",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "waarnemer",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Manuardeo",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Manuardeo heeft het recht om \u00E9\u00E9n (1) waarnemer bij de raad van bestuur te benoemen.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "waarnemer",
"person": null,
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Vandewiele Group NV",
"address": null,
"country": null,
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Vandewiele Group NV heeft het recht om \u00E9\u00E9n (1) waarnemer te benoemen in de raad van bestuur, behalve gedurende de periode waarin \u00E9\u00E9n lid van de raad van bestuur wordt benoemd op voordracht van Vandewiele Group NV.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-04-04",
"filing_date": "2024-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-03-27",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Frederic HELSEN",
"org_rep_person_name": null,
"person_role_at_subject": "notaris"
},
"co_filed_documents": [
"een uitgifte van het proces-verbaal",
"de geco\u00F6rdineerde tekst van statuten",
"een aanwezigheidslijst",
"vijf volmachten",
"het verslag van het bestuursorgaan overeenkomstig artikel 7:179, \u00A71 juncto 7:191 en 7:193 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld in toepassing van 7:228 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:180 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan met betrekking artikel 7:199 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"de verslagen van de commissaris overeenkomstig (i) artikel 7:179, \u00A72, juncto 7:191 en 7:193, (ii) artikel 7:180, tweede lid juncto 7:191, (iii) en artikel 7:155, tweede lid van het Wetboek van vennootschappen en verenigingen"
],
"corrected_publication_numac": null
}04-04-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}04-04-2024 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}04-04-2024 Kapitaalverhoging van €4.024.715,66 tot €34.894.137,79
- €30.869.422,13 → €34.894.137,79
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}04-04-2024 Kapitaalvermindering van €28.036.020,20 tot €6.858.117,59
- €34.894.137,79 → €6.858.117,59
- 3 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 4024715.66,
"currency": "EUR",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 4.024.715,66 EUR, om het van 30.869.422,13 EUR te brengen op 34.894.137,79 EUR, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 28036020.2,
"currency": "EUR",
"after_eur": 6858117.59,
"delta_eur": -28036020.2,
"before_eur": 34894137.79,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, in toepassing van artikel 7:210 van het Wetboek van vennootschappen en verenigingen, te verminderen ten belope van 28.036.020,20 EUR, om het te brengen van 34.894.137,79 EUR op 6.858.117,59 EUR, zonder vernietiging van aandelen.",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 78955.9,
"currency": "EUR",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2024-03-27",
"evidence_quote": "De vergadering beslist een machtiging aan het bestuursorgaan toe te kennen in het kader van het toegestaan kapitaal... om het kapitaal in \u00E9\u00E9n of meerdere malen te verhogen... voor een bedrag van achtenzeventigduizend negenhonderdvijfenvijftig euro en negentig cent (EUR 78.955,90)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}04-04-2024 Kapitaalvermindering van €28.036.020,20 tot €6.858.117,59
- €34.894.137,79 → €6.858.117,59
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 7523,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Sensinnovat",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 7523,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Powergraph",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2833,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Manuardeo",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2893,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn ICT Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 5321,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fund\u002B",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 17360,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AvH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 17360,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Vandewiele Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 14467,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Imec.Xpand",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 9579,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC II FUND ARKIV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 5787,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 2893,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Sensinnovat",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC Arkiv Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Powergraph",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Manuardeo",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fidimec",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn ICT Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Fund\u002B",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Vandewiele Group",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AvH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Qbic II Fund Arkiv",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Qbic Feeder Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Imec.Xpand",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "inschrijvingsrechten_uitgifte",
"n_shares_subscribed": 75,
"contribution_amount_eur": null
}
],
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 34894137.79,
"delta_eur": 4024715.66,
"before_eur": 30869422.13,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Peter Devlin",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 365714,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "person",
"name": "Emmet Lydon",
"share_class": null,
"liberation_pct": 100.0,
"contribution_kind": "geld",
"n_shares_subscribed": 365714,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "gewone",
"n_new_shares": 8125717,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 4024715.66,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 6858117.59,
"delta_eur": -28036020.2,
"before_eur": 34894137.79,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"_demoted_from": "capital_increase",
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-04-04",
"filing_date": "2024-04-02",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-03-27",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"de geco\u00F6rdineerde tekst van statuten",
"een aanwezigheidslijst",
"vijf volmachten",
"het verslag van het bestuursorgaan overeenkomstig artikel 7:179, \u00A71 juncto 7:191 en 7:193 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld in toepassing van 7:228 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:180 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan opgesteld overeenkomstig artikel 7:155 van het Wetboek van vennootschappen en verenigingen",
"het verslag van het bestuursorgaan met betrekking artikel 7:199 juncto 7:191 van het Wetboek van vennootschappen en verenigingen",
"de verslagen van de commissaris overeenkomstig (i) artikel 7:179, \u00A72, juncto 7:191 en 7:193, (ii) artikel 7:180, tweede lid juncto 7:191, (iii) en artikel 7:155, tweede lid van het Wetboek van vennootschappen en verenigingen"
],
"shareholders_after": [
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Universiteit Gent",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Katholieke Universiteit Leuven",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn ICT Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fidimec NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Arkiv Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Powergraph BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V.",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Manuardeo",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Imec.xpand COMMV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn Digital Growth Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "AVH Growth Capital NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fund\u002B NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Feeder Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Capricorn ICT Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Fidimec NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Arkiv Fund NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Powergraph BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Participatiemaatschappij Vlaanderen NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Healthcare Fund II B.V.",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Manuardeo",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Vandewiele Group NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic II Fund Arkiv NV",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Peter Devlin",
"role": null,
"n_shares": 365714,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00EB Delbeke",
"role": null,
"n_shares": 365714,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Sensinnovat BV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Qbic Venture Partners II NV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Thuja Capital Management B.V",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "org",
"name": "Dictys BV",
"role": "gecommanditeerde",
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Nathalie Van Bruaene",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00EB Delbeke",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Fran\u00E7oise Chombar Marie Cyrilla",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Sofie Silvia Pieter Paula Baeten",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Evan Michael Castiglia",
"role": null,
"n_shares": null,
"share_class": null
},
{
"kbo": null,
"pct": null,
"kind": "person",
"name": "Dana\u00E8 Helen\u00E8 Pschych\u00E8 Delbeke",
"role": null,
"n_shares": null,
"share_class": null
}
],
"share_classes_after": [
{
"n_shares": 21521309,
"class_name": "Gewone Aandelen",
"capital_share_eur": 6858117.59,
"voting_rights_per_share": 1.0
},
{
"n_shares": null,
"class_name": "A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": null,
"class_name": "A2",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": null,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}04-04-2024 5 bestuurders benoemd, 6 ontslagnemend
- Sensinnovat BV — Bestuurder
- Qbic Venture Partners II NV — Bestuurder
- Charles-Lambert Marie François Ghislain Beauduin — Bestuurder
- Thuja Capital Management B.V — Bestuurder
- Dictys BV — Bestuurder
- Charles Beauduin — Bestuurder
- An Herremans — Bestuurder
- Evan Castiglia — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles Beauduin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "An Herremans",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Participatiemaatschappij Vlaanderen NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dictys BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sensinnovat BV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Qbic Venture Partners II NV",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Charles-Lambert Marie Fran\u00E7ois Ghislain Beauduin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thuja Capital Management B.V",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dictys BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}04-04-2024 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-03-27",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}25-03-2024 Evan Castiglia benoemd tot bestuurder
- Evan Castiglia — Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
},
"effective_date": "2023-06-30",
"evidence_quote": "en besluit om (door middel van co\u00F6ptatie) Evan Castiglia als bestuurder van de Vennootschap te benoemen, met ingang van de datum van deze besluiten tot 18 augustus 2028."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}25-03-2024 1 bestuurder benoemd, 1 ontslagnemend
- Evan Castiglia — Bestuurder
- Harrold Van Barlingen — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Harrold Van Barlingen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Evan Castiglia",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}26-06-2023 1 bestuurder benoemd, 1 ontslagnemend
- Nathalie Van Bruaene — Vertegenwoordiger van bestuurder
- Tine Bekaert — Vertegenwoordiger van bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Tine Bekaert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vertegenwoordiger van bestuurder",
"person": {
"rrn": null,
"name": "Nathalie Van Bruaene",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}26-06-2023 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}23-06-2023 Thomas Durieux herbenoemd als commissaris
- Thomas Durieux — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Thomas Durieux",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering beslist om de besloten vennootschap BDO Bedrijfsrevisoren, gevestigd te Da Vincilaan 9 bus E6, 1930 Zaventem, met als vertegenwoordiger de heer Thomas Durieux, te herbenoemen als commissaris voor een mandaat van 3 jaar dat een einde neemt onmiddellijk na de gewone algemene ve"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}23-06-2023 2 bestuurders benoemd, 1 ontslagnemend
- Halina Novak — Nieuwe investeerder bestuurder
- BDO Bedrijfsrevisoren — Commissaris
- Luc Debruyne — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Debruyne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Nieuwe Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BDO Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}30-03-2023 Halina Novak benoemd tot bestuurder
- Halina Novak — Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
},
"effective_date": "2023-03-14",
"evidence_quote": "besluit unaniem om (door middel van co\u00F6ptatie) Halina Novak als Nieuwe Investeerder Bestuurder van de Vennootschap te benoemen, met ingang van de datum van deze besluiten tot 18 augustus 2028."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}30-03-2023 1 bestuurder benoemd, 1 ontslagnemend
- Halina Novak — Nieuwe investeerder bestuurder
- Luc Debruyne — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Debruyne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Nieuwe Investeerder Bestuurder",
"person": {
"rrn": null,
"name": "Halina Novak",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES"
}
}21-12-2022 Kapitaalverhoging van €1.500 tot €30.869.422,13
- €30.867.922,13 → €30.869.422,13
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}21-12-2022 Kapitaalverhoging van €12.123.307,63 tot €30.867.922,13
- €18.744.614,50 → €30.867.922,13
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 30867922.13,
"delta_eur": 12123307.63,
"before_eur": 18744614.5,
"subscribers": [
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "THUJA CAPITAL HEALTHCARE FUND II B.V",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "SENSINNOVAT BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "POWERGRAPH BV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "MANUARDEO",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "CAPRICORN ICT ARKIV NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "FUND \u002B NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "AVH Growth Capital",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "VANDEWIELE GROUP NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "IMEC.XPAND COMM VA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "QBIC II FUND ARKIV COMM VA",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
},
{
"kbo": null,
"rrn": null,
"kind": "org",
"name": "CAPRICORN DIGITAL GROWTH FUND NV",
"share_class": null,
"liberation_pct": null,
"contribution_kind": "schuldvordering",
"n_shares_subscribed": null,
"contribution_amount_eur": null
}
],
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte Klasse B",
"n_new_shares": 565189,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 21.45
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 565189,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"share_emission": {
"agio_eur": null,
"share_form": "no_nominal_value",
"share_class": "Gewone",
"n_new_shares": 15000,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 0.1
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 1500.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 15000,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "loss_absorption_only",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_split",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_transfer",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_buyback",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "agio_incorporation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "withdrawal_redemption",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "merger_share_issue",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "statutory_reserve_release",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "vzw_capital_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "other",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-21",
"filing_date": "2022-12-17",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-15",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "BDO Bedrijfsrevisoren BV",
"ibr_number": "22384654",
"mission_type": "quasi_apport",
"individual_name": "Thomas Durieux"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"aanwezigheidslijst",
"12 volmachten",
"de verslagen van de raad van bestuur",
"de verslagen van de commissaris in toepassing van artikelen 7:197, 7:179, 7:180 en 7:155 van het WVV",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 86500,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 41500,
"class_name": "Bevoorrechte Klasse A1 Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 366664,
"class_name": "Bevoorrechte Klasse A2 Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 1871296,
"class_name": "Bevoorrechte Klasse B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}21-12-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}21-12-2022 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Frederic HELSEN",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-12-21",
"filing_date": "2022-12-17",
"act_kind_objet": "KAPITAAL, AANDELEN, STATUTEN (VERTALING, COORDINATIE,"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-12-15",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": {
"summary": "De aandeelhouders verklaren zich vrijwillig van het opstellen van het uitgifteverslag en van het verslag van de commissaris, overeenkomstig artikelen 5:121 en 5:133 van het Wetboek van Vennootschappen en Verenigingen.",
"articles": [
"5:121",
"5:133"
]
},
"restructuring": {
"parties": [
{
"kbo": "0666.442.557",
"name": "Indigo Diabetes NV",
"role": "other",
"address": "Bollebergen 2B bus 5, 9052 Gent",
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "THUJA CAPITAL HEALTHCARE FUND II B.V.",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "SENSINNOVAT BV",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "POWERGRAPH BV",
"role": "contributor",
"address": null,
"is_foreign": true,
"legal_form": "B.V.",
"is_new_company": false,
"jurisdiction_country": "NL"
},
{
"kbo": null,
"name": "MANUARDEO",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "CAPRICORN ICT ARKIV NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "FUND \u002B NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "AVH Growth Capital",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "VANDEWIELE GROUP NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "IMEC.XPAND COMM VA",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "QBIC II FUND ARKIV COMM VA",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": null,
"is_new_company": false,
"jurisdiction_country": null
},
{
"kbo": null,
"name": "CAPRICORN DIGITAL GROWTH FUND NV",
"role": "contributor",
"address": null,
"is_foreign": false,
"legal_form": "NV",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [
"7:155",
"7:179",
"7:180",
"7:197",
"8.2"
],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 580189,
"real_estate_included": false,
"patrimony_description": "De kapitaalverhoging vindt plaats door inbreng in natura van opeisbare schuldvorderingen door aandeelhouders, en door inbreng in geld. De inbreng in natura omvat schuldvorderingen ten laste van de vennootschap, waarvan de waarde wordt vastgesteld op basis van waarderingsmethodes en wordt uitgebracht in Bevoorrechte Klasse B Aandelen. De inbreng in geld is voor 1.500 EUR, uitgegeven in 15.000 Gewon",
"equity_transferred_eur": 12123307.63,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes",
"legal_form": "NV"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Deloitte Legal \u2013 Lawyers",
"person_name": null,
"org_rep_person_name": null
},
"summary_narrative": "De buitengewone algemene vergadering van Indigo Diabetes NV, gehouden op 15 december 2022, besliste een kapitaalverhoging in natura van 12.123.307,63 EUR door inbreng van schuldvorderingen door aandeelhouders, met uitgifte van 565.189 Bevoorrechte Klasse B Aandelen. Daarnaast werd een kapitaalverhoging in geld van 1.500 EUR besloten, met uitgifte van 15.000 Gewone Aandelen. De statuten werden gewijzigd om het nieuwe kapitaal van 30.869.422,13 EUR te reflecteren. Verder werd een materi\u00EBle fout in een vorige publicatie rechtgezet, waarbij 43.635 ESOP Warrants werden vernietigd, en 38.604 nieuwe ",
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"aanwezigheidslijst",
"12 volmachten",
"verslagen van de raad van bestuur en commissaris (art. 7:197, 7:179, 7:180, 7:155 WVV)",
"geco\u00F6rdineerde tekst van statuten"
],
"detected_real_type": "other",
"referenced_correction": {
"prior_pub_date": "2022-09-19",
"what_corrected": "verwijdering van 43.635 ESOP Warrants die niet correct zijn beschreven in de vorige publicatie; correctie van de oorsprong van de vernietigde warrants naar meerdere optieplannen (2016, 2018, 2018bis, 2020)",
"prior_pub_number": "22358569"
},
"should_reroute_to_category": "capital_shares"
}21-12-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-12-15",
"legal_form_change": false
},
"bedrijfsrevisor": {
"quote": "Conclusies van het verslag van de commissaris de dato 15 december 2022, opgesteld door de besloten vennootschap \u201CBDO Bedrijfsrevisoren\u201D, te 9090 Melle, Brusselsesteenweg 92, vertegenwoordigd door Thomas Durieux, in toepassing van de artikelen 7:179, \u00A71, tweede lid en 7: 197, \u00A71, tweede lid van het Wetboek van vennootschappen en verenigingen",
"firm_kbo": "0423846546",
"firm_name": "BDO Bedrijfsrevisoren BV",
"ibr_number": null,
"individual_name": "Thomas Durieux"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "TWEE\u00CBNTWINTIGSTE BESLISSING: Volmacht voor de formaliteiten. De vergadering verleent bijzondere volmacht aan de advocaten en medewerkers van \u201CDeloitte Legal \u2013 Lawyers\u201D, woonstkeuze gedaan hebbende te 9051 Gent, Raymonde de Larochelaan 19B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "Deloitte Legal \u2013 Lawyers",
"scope_categories": [
"share_register_update",
"kbo_filing",
"tax_filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}21-12-2022 Kapitaalverhoging van €12.123.307,63 tot €30.867.922,13
- €18.744.614,50 → €30.867.922,13
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 12123307.63,
"currency": "EUR",
"after_eur": 30867922.13,
"delta_eur": 12123307.63,
"before_eur": 18744614.5,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-15",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 12.123.307,63 EUR, om het van 18.744.614,50 EUR te brengen op 30.867.922,13 EUR, door uitgifte van 565.189 Bevoorrechte Klasse B Aandelen... De vergadering beslist dat de kapitaalverhoging zal worden verwezenlijkt door de inbreng door i) THUJA CAPITAL HEALTHCARE FUND II B.V , ii) SENSINNOVAT BV, iii) POWERGRAPH BV, iv) MANUARDEO, v) CAPRICORN ICT ARKIV NV, vi) FUND \u002B NV vii) AVH Growth Capital, viii) VANDEWIELE GROUP NV, ix) IMEC.XPAND COMM VA, x) QBIC II FUND ARKIV COMM VA en xi) CAPRICORN DIGITAL GROWTH FUND NV... van zekere, vaststaande en opeisbare schuldvorderingen",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 1500.0,
"currency": "EUR",
"after_eur": 30869422.13,
"delta_eur": 1500.0,
"before_eur": 30867922.13,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-15",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 1.500,00 EUR, om het van 30.867.922,13 EUR te brengen op 30.869.422,13 EUR, door inbreng in geld en met de uitgifte van 15.000 Gewone Aandelen... De vergadering beslist dat er onmiddellijk in geld ingeschreven zal worden op de nieuwe aandelen, tegen de prijs van 0,10 EUR elk en dat op ieder aandeel zal onmiddellijk gestort worden ten belope van 100%.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Kapitaalvermindering van €7.228.433,19 tot €18.744.614,50
- €25.973.047,69 → €18.744.614,50
- 2 kapitaalbewegingen in deze akte
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 5569320.9,
"currency": "EUR",
"after_eur": 25973047.69,
"delta_eur": 5569320.9,
"before_eur": 20403726.79,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-18",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van EUR 5.569.320,90, om het van EUR 20.403.726,79 te brengen op EUR 25.973.047,69, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_decrease",
"amount": 7228433.19,
"currency": "EUR",
"after_eur": 18744614.5,
"delta_eur": -7228433.19,
"before_eur": 25973047.69,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-08-18",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, ... te verminderen ten belope van EUR 7.228.433,19, om het te brengen van EUR 25.973.047,69 op EUR 18.744.614,50",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-08-18",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan de advocaten en medewerkers van \u0022Deloitte Legal - Lawyers\u0022, woonstkeuze gedaan hebbende te 9051 Gent, Raymonde de Larochelaan 19B, allen individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "Deloitte Legal - Lawyers",
"scope_categories": [
"KBO",
"tax",
"filing"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}19-09-2022 DEBRUYNE Luc Eddy benoemd tot bestuurder
- DEBRUYNE Luc Eddy — Bestuurder
Technische details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
},
"effective_date": "2022-07-01",
"evidence_quote": "De vergadering bevestigt dat de heer DEBRYNE Luc met ingang van 1 juli 2022 tot bestuurder werd benoemd krachtens een onderhandse beslissing van de algemene vergadering de dato 27 juli 2022, die echter niet werd neergelegd ter publicatie in de Bijlagen bij het Belgisch Staatsblad."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "INDIGO DIABETES",
"legal_form": "NV"
}
}19-09-2022 Kapitaalverhoging van €5.569.320,90 tot €25.973.047,69
- €20.403.726,79 → €25.973.047,69
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 25973047.69,
"delta_eur": 5569320.900000002,
"before_eur": 20403726.79,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}19-09-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}19-09-2022 2 bestuurders benoemd, 2 ontslagnemend
- DEBRUYNE Luc Eddy — Bestuurder
- COMPASS — Bestuurder
- VAN DEN BOSSCHE Jan — Bestuurder
- DEBRUYNE Luc Eddy — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN DEN BOSSCHE Jan",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "DEBRUYNE Luc Eddy",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "COMPASS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0666.442.557",
"name_full": "Indigo Diabetes"
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamNL | Indigo Diabetes |